These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 22017758)
1. Detection of DNA mismatch repair proteins in fresh human blood lymphocytes--towards a novel method for hereditary non-polyposis colorectal cancer (Lynch syndrome) screening. Hassen S; Boman BM; Ali N; Parker M; Somerman C; Ali-Khan Catts ZJ; Ali AA; Fields JZ J Exp Clin Cancer Res; 2011 Oct; 30(1):100. PubMed ID: 22017758 [TBL] [Abstract][Full Text] [Related]
2. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162 [TBL] [Abstract][Full Text] [Related]
3. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419 [TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581 [TBL] [Abstract][Full Text] [Related]
5. Immunoassay for wild-type protein in lymphocytes predicts germline mutations in patients at risk for hereditary colorectal cancer. Fields JZ; Gao Z; Gao Z; Lewis M; Maimonis P; Harvey J; Lynch HT; Boman BM J Lab Clin Med; 2004 Jan; 143(1):59-66. PubMed ID: 14749686 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study. Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011 [TBL] [Abstract][Full Text] [Related]
7. A comparative study of quantitative immunohistochemistry and quantum dot immunohistochemistry for mutation carrier identification in Lynch syndrome. Barrow E; Evans DG; McMahon R; Hill J; Byers R J Clin Pathol; 2011 Mar; 64(3):208-14. PubMed ID: 21177748 [TBL] [Abstract][Full Text] [Related]
8. Clinical characterization and mutation spectrum in Caribbean Hispanic families with Lynch syndrome. Cruz-Correa M; Diaz-Algorri Y; Pérez-Mayoral J; Suleiman-Suleiman W; Gonzalez-Pons Mdel M; Bertrán C; Casellas N; Rodríguez N; Pardo S; Rivera K; Mosquera R; Rodriguez-Quilichini S Fam Cancer; 2015 Sep; 14(3):415-25. PubMed ID: 25782445 [TBL] [Abstract][Full Text] [Related]
9. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence. Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143 [TBL] [Abstract][Full Text] [Related]
10. Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals. Valentin MD; da Silva FC; dos Santos EM; Lisboa BG; de Oliveira LP; Ferreira Fde O; Gomy I; Nakagawa WT; Aguiar Junior S; Redal M; Vaccaro C; Valle AD; Sarroca C; Carraro DM; Rossi BM Fam Cancer; 2011 Dec; 10(4):641-7. PubMed ID: 21681552 [TBL] [Abstract][Full Text] [Related]
11. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines. Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M Tumori; 2014; 100(3):315-20. PubMed ID: 25076244 [TBL] [Abstract][Full Text] [Related]
12. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China. Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542 [TBL] [Abstract][Full Text] [Related]
13. Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers. Müller A; Zielinski D; Friedrichs N; Oberschmid B; Merkelbach-Bruse S; Schackert HK; Linnebacher M; von Knebel Doeberitz M; Büttner R; Rüschoff J; Virchows Arch; 2008 Jul; 453(1):9-16. PubMed ID: 18581137 [TBL] [Abstract][Full Text] [Related]
14. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome. Berginc G; Bracko M; Ravnik-Glavac M; Glavac D Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325 [TBL] [Abstract][Full Text] [Related]
15. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome. Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989 [TBL] [Abstract][Full Text] [Related]
16. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484 [TBL] [Abstract][Full Text] [Related]
17. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491 [TBL] [Abstract][Full Text] [Related]
18. Germline mutation analysis of MLH1 and MSH2 in Malaysian Lynch syndrome patients. Zahary MN; Kaur G; Abu Hassan MR; Singh H; Naik VR; Ankathil R World J Gastroenterol; 2012 Feb; 18(8):814-20. PubMed ID: 22371642 [TBL] [Abstract][Full Text] [Related]
19. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents. Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A; Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]